{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:57:24Z","timestamp":1793120244984,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1001\/jamapsychiatry.2019.0779","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T15:04:38Z","timestamp":1557327878000},"page":"783","source":"Crossref","is-referenced-by-count":199,"title":["Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I\/II Depression"],"prefix":"10.1001","volume":"76","author":[{"given":"Roger S.","family":"McIntyre","sequence":"first","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehala","family":"Subramaniapillai","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Pan","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Carmona","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Shekotikhina","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Federal University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna K.","family":"Soczynska","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria E.","family":"Cosgrove","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Grace","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole E.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiley","family":"Dunlap","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Suppes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"yoi190021r1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"yoi190021r2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-pharmtox-101714-123102","article-title":"Introduction to the theme \u201cprecision medicine and prediction in pharmacology.\u201d","volume":"55","author":"Insel","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"yoi190021r3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.31887\/DCNS.2017.19.1\/rmcintyre","article-title":"Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.","volume":"19","author":"Subramaniapillai","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"11","key":"yoi190021r4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.","volume":"2","author":"Passos","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"yoi190021r5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbi.2017.06.005","article-title":"Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses.","volume":"65","author":"Aas","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"2","key":"yoi190021r6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.2016.18.issue-2","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord"},{"issue":"2","key":"yoi190021r7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","article-title":"Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions.","volume":"23","author":"Kappelmann","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"1","key":"yoi190021r8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"yoi190021r9","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","author":"Felger","journal-title":"Mol Psychiatry"},{"key":"yoi190021r10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amsu.2016.07.023","article-title":"The change of neutrophils\/lymphocytes ratio in migraine attacks: a case-controlled study.","volume":"10","author":"Karabulut","year":"2016","journal-title":"Ann Med Surg (Lond)"},{"issue":"2","key":"yoi190021r11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/hed.2006.46.issue-2","article-title":"Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally.","volume":"46","author":"Sarchielli","year":"2006","journal-title":"Headache"},{"key":"yoi190021r13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcjd.2013.01.009","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: introduction.","volume":"37","author":"Cheng","year":"2013","journal-title":"Can J Diabetes"},{"key":"yoi190021r14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.coph.2016.06.007","article-title":"Pharmacologic implications of inflammatory comorbidity in bipolar disorder.","volume":"29","author":"Rosenblat","year":"2016","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"yoi190021r15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/acps.2017.135.issue-4","article-title":"Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders.","volume":"135","author":"Etain","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"yoi190021r16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0002-9343(99)00235-1","article-title":"Adult health status of women with histories of childhood abuse and neglect.","volume":"107","author":"Walker","year":"1999","journal-title":"Am J Med"},{"key":"yoi190021r17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability.","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"yoi190021r18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","article-title":"Defining remission by cut off score on the MADRS: selecting the optimal value.","volume":"72","author":"Hawley","year":"2002","journal-title":"J Affect Disord"},{"key":"yoi190021r19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2017.08.023","article-title":"Interaction between childhood maltreatment on immunogenetic risk in depression: discovery and replication in clinical case-control samples.","volume":"67","author":"Cohen-Woods","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"5","key":"yoi190021r20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2015.67","article-title":"Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-a.","volume":"21","author":"Baumeister","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"3","key":"yoi190021r21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/acps.2014.129.issue-3","article-title":"Childhood maltreatment and inflammatory markers: a systematic review.","volume":"129","author":"Coelho","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"yoi190021r22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jneuroim.2018.02.018","article-title":"Childhood trauma and increased peripheral cytokines in young adults with major depressive: population-based study","volume":"319","author":"Pedrotti Moreira","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"12","key":"yoi190021r23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/archpediatrics.2009.214","article-title":"Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers.","volume":"163","author":"Danese","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"yoi190021r24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.psyneuen.2016.07.205","article-title":"Cytokine levels in major depression are related to childhood trauma but not to recent stressors.","volume":"73","author":"Grosse","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"yoi190021r25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/acps.2011.124.issue-6","article-title":"Childhood maltreatment and clinical outcomes of bipolar disorder","volume":"124","author":"Daruy-Filho","year":"2011","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"yoi190021r26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/jcpp.12623","article-title":"Moderators of treatment response to trauma-focused cognitive behavioral therapy among youth in Zambia.","volume":"57","author":"Kane","year":"2016","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"yoi190021r27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/archpsyc.65.4.409","article-title":"Elevated inflammation levels in depressed adults with a history of childhood maltreatment.","volume":"65","author":"Danese","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"yoi190021r28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/CIR.0000000000000229","article-title":"Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association.","volume":"132","author":"Goldstein","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"yoi190021r29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.2017.135.issue-5","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"yoi190021r30","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis.","volume":"55","author":"K\u00f6hler","year":"2018","journal-title":"Mol Neurobiol"},{"key":"yoi190021r31","first-page":"1","article-title":"Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.","author":"Marrie","year":"2017","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"1","key":"yoi190021r32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/mp.2017.205","article-title":"Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.","volume":"23","author":"Leighton","year":"2018","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi190021r33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/YIC.0000000000000058","article-title":"Predictors of placebo response in bipolar depression.","volume":"30","author":"Nierenberg","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"yoi190021r12","unstructured":"International Headache Society. ICHD\/Guidelines. https:\/\/www.ihs-headache.org\/ichd-guidelines. Accessed on April 1, 2018."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/article-pdf\/76\/8\/783\/17754214\/jamapsychiatry_mcintyre_2019_oi_190021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T09:56:11Z","timestamp":1607680571000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2732872"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0779","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,1]]}}}